These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9644603)

  • 41. A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.
    Del Favero A; Menichetti F; Martino P; Bucaneve G; Micozzi A; Gentile G; Furno P; Russo D; D'Antonio D; Ricci P; Martino B; Mandelli F;
    Clin Infect Dis; 2001 Oct; 33(8):1295-301. PubMed ID: 11565068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study].
    Sampi K; Hattori M
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1315-20. PubMed ID: 1503486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical evaluation of panipenem/betamipron as a second line chemotherapy in severe infections associated with hematological disorders].
    Nakazawa N; Okamoto T; Kobayashi M; Iwai T; Sasai Y; Tamura A; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tuda S; Ohkawara Y
    Jpn J Antibiot; 1998 Aug; 51(8):509-20. PubMed ID: 9836123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunosuppression in myelo-and lymphoproliferative disorders.
    Papa G; Cudillo L; Rainaldi A; Dentamaro T
    Rays; 1994; 19(4):417-23. PubMed ID: 7871218
    [No Abstract]   [Full Text] [Related]  

  • 45. [A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
    Misawa S; Tsuda S; Taniwaki M; Horiike S; Ariyama Y; Hirakawa K; Ueda Y; Kaneko H; Nakao M; Kashima K
    Jpn J Antibiot; 1995 Apr; 48(4):514-21. PubMed ID: 7540219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of severe infections in hematologic malignancies with piperacillin sodium].
    Kubota Y; Ohnishi H; Murata M; Nagai M; Ikeda K; Tanaka T; Irino S
    Jpn J Antibiot; 1991 Mar; 44(3):317-23. PubMed ID: 1880913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
    Nagao T; Komatsuda M; Yamauchi K; Nozaki H; Arimori S
    Tokai J Exp Clin Med; 1981 Oct; 6(4):415-20. PubMed ID: 6459664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
    Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
    Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
    Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
    Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
    Girmenia C; Alimena G; Latagliata R; Morano SG; Celesti F; Coppola L; Spadea A; Tosti S; Mecarocci S; D'Elia GM; Tafuri A; Cimino G; Mandelli F
    Haematologica; 1999 Sep; 84(9):814-9. PubMed ID: 10477455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Amikacin in single daily doses in children with fever].
    Solórzano-Santos F; Miranda-Novales MG; Díaz-Peña R; Bernaldez-Ríos R; Díaz-Bensussen S; Rivera-Márquez H; Díaz-Ponce H
    Rev Invest Clin; 1996; 48(1):13-8. PubMed ID: 8815481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
    Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative study of cefpirome and ceftazidime in complicated urinary tract infections].
    Naide Y; Aso Y; Oshi M; Kumamoto Y; Hirose T; Machida T; Tsuchida S; Suzuki K; Orikasa S; Kawada Y
    Hinyokika Kiyo; 1991 Apr; 37(4):447-64. PubMed ID: 1892004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The treatment outcomes of 21 cases of rapidly growing mycobacteria related pulmonary disease].
    Chen PR; Tan SY
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):182-5. PubMed ID: 23856140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Infection in severe neutropenia: analysis of 140 episodes].
    Gutiérrez J; Bronfman L; Lorca J; Pinto ME; Torrens M; Garcia ME; Barrientos A; Palma T
    Rev Med Chil; 1989 Oct; 117(10):1141-9. PubMed ID: 2519358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
    Sawae Y; Niho Y; Harada M; Shibuya T; Okamura T; Asano Y; Taniguchi S; Murakawa M; Toyoshima T; Kozuru M
    Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections.
    Karachalios GN; Houpas P; Tziviskou E; Papalimneou V; Georgiou A; Karachaliou I; Halkiadaki D
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):561-4. PubMed ID: 9799062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical study on a concomitant therapy with fluconazole and human recombinant granulocyte colony stimulating factor in the treatment of systemic fungal infections with hematological disorders].
    Kitamura K; Miyagawa K; Urabe A; Sato H; Obayashi Y; Aoki I; Takaku F; Togawa A; Shindou E; Wakabayashi Y; Ohshima T; Horikoshi A; Nomura T; Ohki I; Suzuki K; Kamakura M; Oguchi A; Toyama K; Yaguchi M; Aoki N; Kato A; Mizoguchi H; Masuda M; Irie S; Fujioka S
    Jpn J Antibiot; 1996 Dec; 49(12):1062-72. PubMed ID: 9032593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.